Table 4.
Summary of the 18 genes that are significant analyzing rare variants only.
Chromosome | Position | Gene | P-value | Frequency cutoff | N rare variants |
---|---|---|---|---|---|
2 | 102,418,689–102,452,565 | IL18RAP | 2.31E−06 | 0.3% | 269 |
2 | 212,999,691–213,152,427 | IKZF2 | 1.45E−08 | 0.5% | 212 |
3 | 3,066,324–3,126,613 | IL5RA | 7.19E−07 | 0.5% | 235 |
5 | 131,641,714–131,797,063 | FNIP1 | 4.93E−07 | 0.5% | 445 |
6 | 31,268,749–31,272,130 | HLA-C | 4.84E−07 | 1% | 479 |
6 | 31,620,715–31,637,771 | PRRC2A | 4.14E−07 | 1% | 1,261 |
6 | 32,041,153–32,115,334 | TNXB | 6.99E−08 | 0.5% | 2,043 |
6 | 32,517,353–32,530,287 | HLA-DRB5 | 9.02E−07 | 1% | 77 |
9 | 4,984,390–5,129,948 | JAK2 | 1.77E−10 | 0.3% | 551 |
9 | 6,215,786–6,257,983 | IL33 | 1.17E−34 | 0.5% | 153 |
12 | 111,405,923–111,451,623 | SH2B3 | 3.35E−07 | 0.1% | 429 |
14 | 23,117,306–23,119,255 | CEBPE | 7.81E−09 | 1% | 157 |
15 | 79,898,840–79,923,702 | ST20 | 1.93E−06 | 0.5% | 23 |
16 | 30,934,376–30,960,104 | FBXL19 | 3.36E−07 | 1% | 255 |
17 | 4,630,919–4,642,294 | ALOX15 | 4.22E−11 | 0.1% | 364 |
19 | 3,172,346–3,180,332 | S1PR4 | 5.12E−17 | 1% | 271 |
22 | 17,084,954–17,115,694 | IL17RA | 6.89E−08 | 0.5% | 532 |
22 | 36,913,628–36,940,439 | CSF2RB | 6.60E−13 | 0.1% | 290 |
The P-value represents the value corresponding to the lowest frequency cutoff yielding a significant association. Both the allele frequency cutoff and the number of rare variants included in the test are also shown per gene.